While the holiday season put a (deceptive) dent in the number of registered respiratory infections in Hungary, the ...

While the holiday season put a (deceptive) dent in the number of registered respiratory infections in Hungary, the ...

The NHS is under intense pressure amid a rise in cases of a globally spreading virus - with hospitals across the nation ...

Flu season is here in New Jersey, but other illnesses are in full swing in the Garden State. Here are the symptoms and how ...

Moderna shares will likely remain under scrutiny after plunging nearly 17% Monday as the embattled drug maker slashed its ...

The northern hemisphere is facing not only a surge of COVID infections, but flu, RSV, and norovirus cases are skyrocketing.

Moderna pulled in most of its revenue last year from its COVID-19 vaccine, Spikevax, which brought in more than $3 billion in sales. Regulators also approved a Moderna vaccine for RSV, or respiratory ...

Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.

Mahmoudi believes there’s one reason emergency visits, and hospitalizations, have declined. “The decrease in hospitalization can be attributed directly to vaccines and the success of them,” ...

There are fears the NHS may be set to face its worst ever winter flu season after cases soared around the country in late ...

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...